Can I Get a Michigan Medical Marijuana Card for Agitation of Alzheimer's Disease?

Yes — agitation of alzheimer's disease qualifies under the Michigan Medical Marihuana Program

Agitation of Alzheimer's disease is explicitly listed as a Category A qualifying condition on the Michigan MMMP Physician Certification Form. The behavioral and psychological symptoms of dementia (BPSD) — agitation, aggression, sleep disruption, sundowning — affect most patients with moderate to advanced Alzheimer's at some point and are among the most distressing aspects of the disease for both patients and caregivers. Standard treatments (antipsychotics, sedatives) carry significant safety concerns in elderly dementia patients, making cannabis an option worth careful consideration.

Common symptoms

• Agitation, restlessness, or pacing
• Verbal or physical aggression
• Sleep disturbance and sundowning
• Anxiety and emotional lability
• Resistance to care
• Wandering
• Often distressing to both patient and caregiver

How medical cannabis may help

Low-dose THC and CBD have been studied for agitation in dementia, with several small trials showing reduced agitation scores, improved sleep, and reduced caregiver burden. The endocannabinoid system declines with age and with Alzheimer's pathology — restoring some of that signaling may help modulate the agitation circuits that drive BPSD. Cannabis is typically administered by a designated caregiver in standardized doses (often as an oil or tincture).

Evidence base

Multiple small clinical trials and observational studies support low-dose cannabinoids in dementia agitation. Volicer et al. (1997) and Walther et al. (2006) demonstrated reduced disturbed behavior and improved appetite with synthetic THC. A 2019 Israeli observational study in dementia patients reported reduced agitation, improved sleep, and reduced reliance on antipsychotics. The 2017 NASEM report noted limited but suggestive evidence. Larger trials are ongoing.

Michigan certification requirements

Documentation of Alzheimer's diagnosis (neurology, geriatrics, or primary care notes), a description of the agitation/BPSD symptoms and their impact, and a list of current medications are helpful. Alzheimer's patients with cognitive impairment require a designated caregiver per Michigan rules — typically a spouse, adult child, or other family member who administers the cannabis on a defined schedule.